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Abstrak
Latar belakang: Hiperkolesterolemia merupakan penyebab penyakit kardiovaskular yang dapat 
menyebabkan inkapasitasi dalam penerbangan. Salah satu cara untuk mengontrol hiperkolesterolemia 
adalah dengan minum obat antikolesterol golongan statin, namun belum ada instrumen yang dapat 
digunakan untuk mengukur kepatuhan minum obat statin di kalangan penerbang militer di Indonesia. 
Tujuan penelitian ini adalah melakukan uji validitas dan reliabilitas kuesioner Morisky Medication 
Adherence Scale 8 (MMAS-8) versi bahasa Indonesia untuk mengukur kepatuhan konsumsi statin pada 
penerbang militer di Indonesia.
Metode: MMAS 8 diterjemahkan secara sistematik ke dalam bahasa Indonesia. Uji validitas dan 
reliabilitas MMAS 8 pada 40 penerbang militer di Skadron Udara Halim Perdanakusuma dilaksanakan 
pada tanggal 6 April-15 Mei 2016. Validitas diuji dengan validitas kriteria. Reliabilitas diuji dengan 
konsistensi internal dan uji ulang (test-retest).
Hasil: Sebagian besar penerbang (52,5%) memiliki kadar kolesterol tinggi (>200 mg/dL) dan tingkat 
kepatuhan minum statin yang rendah (74,4%). Didapatkan korelasi negatif lemah dan tidak ditemukan 
hubungan bermakna antara antara kadar kolesterol dan tingkat kepatuhan minum statin (koefisien 
Spearman -0,199; p=0,218). Konsistensi internal moderat (Cronbach’s α=0,759) dengan reliabilitas tes 
ulang yang baik (koefisien Spearman=0,860). 
Kesimpulan: Hasil uji validitas dan reliabilitas MMAS 8 versi bahasa Indonesia pada penerbang militer. 
(Health Science Journal of Indonesia 2016;7(2):129-133)
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Abstract
Background: Hypercholesterolemia is the cause of cardiovascular disease which lead to inflight 
incapacitation. One of the way to control hypercholesterolemia is using statin medication, however there 
has not been an instrument to measure statin adherence in military pilots in Indonesia. The aim of this 
study was to analyze the validity and reliability of MMAS 8 Bahasa version to measure statin adherence 
among military pilot in Indonesia. 
Methods: MMAS 8 sistematically translated into Bahasa. Validity and reliability test among 40 military 
pilots in Halim Perdanakusuma Air Force Base was held on April 06th - May 15th 2016. Validity was 
confirmed using crirerion-related validity. Reliability was tested for internal consistency and test-retest 
reliability. 
Results: Most of the pilots (52.5%) had high cholesterol level and 74.4% had low statin adherence. 
Negative weak correlation and no significant association between cholesterol and statin adherence level 
(Spearman coefficient -.199, p=0.218) was found. Moderate internal consistency and excellent test-retest 
reliability were found (Cronbach’s α=0.759; Spearman correlation=0.860).
Conclusions: Validity and reliability of MMAS 8 Bahasa version has not been able to be used to measure statin 
adherence among military pilots in Indonesia. (Health Science Journal of Indonesia 2016;7(2):129-133)
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Hypercholesterolemia may lead to cardiovascular 
disease which is the leading cause of worldwide 
morbidity and mortality.1,2 Rintasanti study in 
Aviation Medical Center Jakarta among civilian pilots 
underwent routine medical examination on May 
2013 found the prevalence of hypercholesterolemia 
was 55.4%.3 
Hypercholesterolemia or high cholesterol is a 
condition of total blood cholesterol is > 240 mg/dL.4 
In aviation, it has serious impact such as vertigo, 
syncope, flight illusion and cardiovascular disease 
which strike unexpectedly and lead to incapacitation 
which has serious and life-threatening impact for 
passengers and cabin crews.5 
According to the National Cholesterol Education 
Program–Adult Treatment Panel III (NCEP-ATP 
III) guidelines which is in line with the guideline of 
International Civil Aviation Organization (ICAO) 
and the Aerospace Medical Association (AsMA), 
the first line hypercholesterolemia pharmacologic 
therapy is statin.6,7 Statins long term use has been 
shown to be safe and beneficial for cardiovascular 
disease prevention.7 Although many studies have 
shown that statins have pleiotropic effects that can 
reduce pain and improve activity endurance, but 
statin adherence has not been optimal.8,9 There is 
no measurement standard for statin adherence.10 
The most inexpensive and easy measurement is 
subjective measurements using Morisky Medication 
adherence Scale (MMAS) questionnaires  developed 
by Morisky et al which consists of 8 items.11 Validity 
and reliability of MMAS 8 has been tested to measure 
antihypertensive drugs adherence in 1367 patients in 
Los Angeles and 200 patients in Iran.11,12 MMAS 8 
has also been translated and validated for 223 and 
41 patients with type 2 diabetes mellitus in Malaysia 
and China.13,14 In addition MMAS 8 was also used 
by Foraih to study the relationship between diet, 
physical activity and lifestyle to statin adherence 
in 200 hypercholesterolemic patients in Kuwait.15 
However, its validity and reliability has never been 
tested to measure statin adherence among military 
pilots in Indonesia. 
METHODS
Validity and reliability test for MMAS 8 among statin 
consuming military pilots in Halim Perdanakusuma 
Air Force Base was held on April 6th until May 
15th 2016. The adherence rate was obtained from 
twice questionnaires fulfilment in a span of 15 days. 
Blood cholesterol levels data was obtained from the 
medical records available in the squadron clinic.
Classification of adherence level was based on 
MMAS 8 total score i.e score <6 categorized as 
low adherence, score 6-8 categorized as moderate 
adherence, and a score of 8 categorized as high 
adherence.
Blood cholesterol level criteria was classified into 
normal cholesterol (<200 mg / dL), borderline (201-
239 mg / dL) and high cholesterol (> 240 mg / dL).
Validity was tested using criterion-related validity 
which was analyzed using correlation coefficient 
between adherence level criteria and blood cholesterol 
level criteria. Internal consistency reliability test was 
analyzed with Cronbach α and stability test was 
analyzed with correlation coefficient comparing 
the MMAS 8 total score from the first and second 
data. Data analysis was performed using SPSS 
version 20. Ethical approval was obtained from the 
Health Research Ethics Committee of the Faculty of 
Medicine, University of Indonesia, Jakarta.
Questionnaire translation was conducted by two 
different sworn translators.  Questionnaire translation 
phases are as follows:
1. MMAS 8 was translated from English into 
Bahasa by an independent sworn translator.
2. Bahasa version questionnaire was translated back 
into English by another sworn translator. Any 
inconsistency would be discussed in a meeting 
to formulate the final form of questionnaire that 
was test ready.
3. The questionnaire that had been translated into 
Bahasa would be distributed to five people who 
understands Bahasa well and were not included 
in the study but has the same characteristics as 
the subjects. Items that were not well understood 
would be reviewed by the researchers.
4. The final version of the Bahasa version 
questionnaire had been completed and ready to 
be tested for validity and reliability.
RESULTS
The number of subjects participated in the study 
was 40 whose age between 24-38 years old. Table 
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1 showed that most of the pilots (52.5%) were 26-
30 years old and classified as having high blood 
cholesterol (> 200 mg / dL), 74.4% of subjects had 
low statin adherence level and there was no pilot 
with high adherence level.
Table 1. Characteristics of subjects
Characteristics Total sample (N)
Age
  < 25 years
  26-30 years
  > 31 years
5 (12,5%)
21 (52,5%)
14 (35,0%)
Total blood cholesterol
  < 200 mg/dL
  201-239 mg/dL
  > 240 mg/dL
19 (47,5%)
17 (42,5%)
4 (10,0%)
Statin adherence
   Low
   Moderate
   High
29 (74,4%)
11 (25,6%)
0 
Criterion-Related Validity
Validity was assessed with criterion-related validity 
which showed the relationship between adherence 
level and total blood cholesterol.
Table 2 showed among 40 subjects, 29 subjects had 
low adherence level and 11 subjects had moderate 
adherence level. Among 29 low adherence subjects, 
58.6% had high blood cholesterol level (>200 mg/ 
dL) and among 11 moderate adherence subjects, 
63.6% had normal blood cholesterol level. Negative 
weak correlation and no significant association 
between total blood cholesterol level and MMAS 8 
total score were found (r = -0.199; p = 0.218).
Table 2. Relationship between adherence criteria and total 
blood cholesterol.
Total blood cholesterol
Low adherence
(score < 6)
Medium 
adherence
(score 6-8)
< 200 mg/dL 12 (41,4%) 7 (63,6%)
0,293201-239 mg/dL 13 (44,80%) 4 (36,4%)
> 240 mg/dL 4 (13,8%) 0
Total 29 (100%) 11 (100%)
Median of total blood cholesterol 204 mg/dL.
Internal consistency
Table 3 showed the test of internal consistency with 
Cronbach’s α for the eighth item MMAS 8 questions 
was 0.759. The correlation coefficient for each item 
to the total score ranged from 0.008 to 0.860. The 
smallest coefficient was on the question about taking 
the drug the day before the test (item 5), but the 
value of Cronbach’s α if the item was removed only 
slightly increase to 0.787. Overall, the correlation of 
each item if removed to the value of Cronbach’s α 
tend to decrease so no changes was implied to the 
items of MMAS. 
Questionnaire stability
Table 4 showed the stability of this questionnaire 
was very good (r = 0.860). The most inconsistent 
response were in the questions about the degree 
of difficulty remembering treatment (item 8) and 
also about taking medication the day before data 
collection (item 5).
Table 3. Internal consistency of MMAS 8 Bahasa version
Response Corrected 
item-total 
correlation
Cronbach’s 
alpha if item 
deleted
Questions Yes (%) No (%)
Sometimes forget to take medication 26 (65.0%) 14 (35.0%) 0.860 0.674
Any day did not take medication 25 (62.5%) 15 (37.5%) 0.666 0.704
Stop medication without warning to 
doctor
15 (37.5%) 25 (62.5%) 0.419 0.740
Forget medication when travelling 26 (65.0%) 14 (35.0%) 0.764 0.690
Take medication yesterday 7 (17.5%) 33 (82.5%) 0.008 0.787
Stop medication when cholesterol is 
controlled
32 (80.0%) 8 (20.0%) 0.391 0.746
Distressed for following treatment 6 (15.0%) 34 (85.0%) 0.305 0.757
Difficulty to remember taking 
anticholesterol
Never Almost never Sometimes Frequently Always
15 (37.5%) 4(10.0%) 14 (35.0%) 5 (12.5%) 2 (5.0%) 0.670 0.753
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DISCUSSION
This study was the first study aimed to test the validity 
and reliability of the MMAS 8 questionnaire to statin 
adherence among military pilots in Indonesia.
The result of validity results in this study demonstrated 
a negative weak correlation and no significant 
relationship were found between total score MMAS 
8 with total cholesterol levels (Spearman Rank 
Order coefficient -0.199; p: 0.218). MMAS 8 total 
score negative correlation  with blood pressure and 
HbA1c levels were also obtained on research in Iran 
and Malaysia with a stronger correlation coefficient 
to systolic blood pressure -0.306, diastolic blood 
pressure -0.279 and HbA1C levels -0.431.12,13
Reliability test results showed the internal 
consistency that is lower than the initial research 
Morisky in the US, but it was better compared to 
studies in other countries (Cronbach’s α: 0.759) with 
higher stability than studies in Malaysia and China 
(Spearman correlation coefficients: 0.860).11-14 Test-
retest reliability demonstrated that inconsistent 
responses were in the difficulty of remembering 
treatment (item 8) and about taking medication the 
day before data collection (item 5). It could appear 
because item 8 is not “yes-no” question as another 
items, but using 5 Likert scale so the responses are 
more varied. While inconsistency in the question 
about taking medication the day before the study 
(item 5) could occur because of the caution in the 
first questionnaire so the respondents were more 
likely to remember to take medication ahead to the 
second questionnaire. However, Cronbach’s alpha if 
item 5 deleted only slightly increased to 0.787 so no 
changes was applied in the item.
Limitations of this study was the data of total 
cholesterol level was obtained from medical records 
Tabel 4. Test-retest reliability of MMAS 8 Bahasa version
Questions Consistent Inconsistent Spearman correlation coefficient 
Sometimes forget to take medication 36 (90.0%) 4 (10.0%)
0.860
Any day did not take medication 34 (85.0%) 6 (15.0%)
Stop medication without warning to doctor 32 (80.0%) 8 (20.0%)
Forget medication when travelling 36 (90,0%) 4 (10.0%)
Take medication yesterday 28 (70.0%) 12 (30.0%)
Stop medication when cholesterol is controlled 36 (90.0%) 4 (10.0%)
Distressed for following treatment 36 (90.0%) 4 (10.0%)
Difficulty to remember taking anticholesterol 26 (65.0%) 14 (35.0%)
regardless of the treatment duration and therefore 
could not describe the blood cholesterol level when 
collecting data. Statins may improve blood lipid 
profiles within 4 weeks and 1 week discontinuation 
of statins can increase blood cholesterol levels so 
time factor when respondents were taking statins 
may have an impact on blood cholesterol levels 
when data collection.16 This was in contrast to other 
studies that examine blood pressure, blood sugar 
levels or HbA1C levels at the same time with data 
collection.11-14
Another limitation is less variation of the study 
subjects. Military pilot consists of transport, fighter 
aircraft and helicopter pilots. In this study, subjects 
consist only of transport and helicopter pilots.
In conclusion, validity and reliability of MMAS 
8 Bahasa version has not been able to be used to 
measure statin adherence among military pilots in 
Indonesia.
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